Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?

Key Points In this and prior small series, hybrid transcatheter pulmonary valve replacement (TPVR) yields similar acute outcomes to surgical pulmonary valve replacement (PVR) in patients with postoperative pulmonary regurgitation and a right ventricular outflow tract (RVOT) that is too large for conventional TPVR By expanding the options for pulmonary valve replacement (PVR) in high‐risk patients, hybrid TPVR will broaden the therapeutic toolset and facilitate more personalized, patient‐specific management in complex circumstances Although surgical exposure and RVOT size reduction allows implantation of a prosthetic valve without cardiopulmonary bypass in this population, the morbidity advantage of TPVR is reduced and the net benefit to the patient must still be established